AUTL NASDAQ
Autolus Therapeutics plc
1W: -4.3%
1M: -20.5%
3M: +9.2%
YTD: -4.8%
1Y: +6.6%
3Y: -23.3%
5Y: -71.7%
$1.78
-0.07 (-3.78%)
Weekly Expected Move ±6.9%
$2
$2
$2
$2
$2
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$117M
Revenue
+292.0% YoY
$-280M
Net Income
-22.9% YoY
$-237M
Free Cash Flow
+23.9% YoY
55.2%
Gross Margin
-95.9%
Op. Margin
-85.6%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-132.9%
ROA-46.1%
ROIC451.5%
Valuation
P/E-1.7
P/B6.3
EV/EBITDA-1.4
Leverage
Debt/Equity1.12
Current Ratio4.89
Interest Cov.-4.9x
Quality Scores
Piotroski F3/9
Altman Z-4.31
Beneish M-3.19